Chemoinformaics analysis of 3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL
Molecular Weight | 370.439 | nRot | 22 |
Heavy Atom Molecular Weight | 336.167 | nRig | 0 |
Exact Molecular Weight | 370.22 | nRing | 0 |
Solubility: LogS | 0.182 | nHRing | 0 |
Solubility: LogP | -0.989 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
nHA | 9 | APOL | 56.609 |
nHD | 2 | BPOL | 46.261 |
QED | 0.234 |
Synth | 1.99 |
Natural Product Likeliness | 0.02 |
NR-PPAR-gamma | 0.186 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.003 |
Pgp-sub | 0.005 |
HIA | 0.385 |
CACO-2 | -4.851 |
MDCK | 0.0000132 |
BBB | 0.038 |
PPB | 0.101459 |
VDSS | 0.401 |
FU | 0.425344 |
CYP1A2-inh | 0.001 |
CYP1A2-sub | 0.026 |
CYP2c19-inh | 0.006 |
CYP2c19-sub | 0.048 |
CYP2c9-inh | 0 |
CYP2c9-sub | 0.001 |
CYP2d6-inh | 0 |
CYP2d6-sub | 0.013 |
CYP3a4-inh | 0.003 |
CYP3a4-sub | 0.075 |
CL | 1.82 |
T12 | 0.516 |
hERG | 0.989 |
Ames | 0.036 |
ROA | 0.006 |
SkinSen | 0.926 |
Carcinogencity | 0.518 |
EI | 0.989 |
Respiratory | 0.001 |
NR-Aromatase | 0.749 |
Antiviral | Yes |
Prediction | 0.60042 |